EXTRANODAL MARGINAL ZONE B-CELL LYMPHOMA (MALT TYPE) STAGE IV

This adverse event was reported 12 times

EXTRANODAL MARGINAL ZONE B-CELL LYMPHOMA (MALT TYPE) STAGE IV is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 PIMECROLIMUS 1 0.0006
1 GLOFITAMAB 1 0.0004
2 BENDAMUSTINE HCL 1 0.0001
3 OBINUTUZUMAB 1 0.0001
4 TACROLIMUS OINTMENT 0.1% 5 0.0000
5 TACROLIMUS EXTENDED-RELEASE CAPSULES 5 0.0000
6 ERGOCALCIFEROL 1 0.0000
7 TACROLIMUS 5 0.0000
8 GEMCITABINE HYDROCHLORIDE 1 0.0000
9 RITUXIMAB 3 0.0000
See all drugs enriched for association with EXTRANODAL MARGINAL ZONE B-CELL LYMPHOMA (MALT TYPE) STAGE IV